Zimmer Biomet, Medtech Mergers And Acquisitions Accelerate – InkFreeNews.com

Recent consolidations from Zimmer Biomet have been reflective of a growing merger and acquisition market in the medical technology sector, according to experts. Photo from Google Maps.

News Release

WARSAW — Merger and acquisition activity in the medical technology sector has accelerated this year, with Warsaw-based Zimmer Biomet playing a leading role in high-profile deals.

J.P. Morgan reported that the first quarter saw 57 medtech transactions valued at more than $9.2 billion, the most active period since early 2022. Notable deals included Stryker’s $4.9 billion acquisition of Inari Medical and Zimmer Biomet’s $1.2 billion purchase of Paragon 28, completed in April. The Paragon 28 acquisition expands Zimmer’s presence in the foot and ankle market, with new offerings in fracture, trauma, deformity correction and joint replacement.

Zimmer Biomet also announced a July agreement to acquire Monogram Technologies of Austin, Texas, in a deal valued at about $177 million. Monogram has developed an FDA-cleared robotic system for total knee replacement that Zimmer plans to commercialize with its implants in 2027.

Industry analysts say large medtech deals remain strong despite headwinds. While early-stage acquisitions have slowed since 2023, attorneys and advisors report that established firms continue to pursue strategic targets, particularly where intellectual property can provide long-term value.

PwC Global noted that optimism for megadeals above $10 billion has faded, with most expected to fall in the $1 billion–$10 billion range through late 2025. Analysts cite regulatory and reimbursement uncertainties, as well as high borrowing costs, as factors complicating deal structures.

Still, observers expect steady activity into 2026 as companies pursue innovation, diversify portfolios and strengthen their positions in specialized care markets.

_{Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.}